Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CEUS for Kidney Lesion Diagnosis in CKD
NCT03196076Phase 2Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Aug 2017
- Primary completion
- Mar 2021
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of perflutren lipid microspheres in kidney neoplasm, sponsored by University of North Carolina at Chapel Hill. Started Aug 2017; status: completed.
02
Drugs
perflutren lipid microspheres
03
Conditions
kidney neoplasm
Beyond the preview
Go deeper on NCT03196076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03196076.